DiaSorin S.p.A. (DSRLF)
USD 109.01
(0.0%)
USD 109.01
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 235.78 Million EUR | -36.38% |
| 2022 | 409.06 Million USD | -19.04% |
| 2021 | 505.27 Million USD | 23.98% |
| 2020 | 407.53 Million USD | 60.42% |
| 2019 | 254.04 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 141.27 Million EUR | 10.78% |
| 2024 Q1 | 69.06 Million EUR | 15.29% |
| 2023 FY | 260.24 Million USD | -36.38% |
| 2023 Q2 | 142.02 Million USD | 118.17% |
| 2023 Q4 | 105.57 Million USD | 82.03% |
| 2023 Q1 | 65.1 Million EUR | -65.92% |
| 2023 Q3 | 58 Million EUR | -59.16% |
| 2022 Q2 | 203.71 Million USD | 60.4% |
| 2022 Q1 | 127 Million EUR | -44.16% |
| 2022 FY | 409.06 Million USD | -19.04% |
| 2022 Q4 | 191.04 Million USD | 112.27% |
| 2022 Q3 | 90 Million EUR | -55.82% |
| 2021 Q1 | 121.21 Million EUR | -40.46% |
| 2021 Q2 | 217.1 Million EUR | 79.1% |
| 2021 Q3 | 132.96 Million EUR | -38.76% |
| 2021 Q4 | 227.42 Million EUR | 71.05% |
| 2021 FY | 505.27 Million USD | 23.98% |
| 2020 Q2 | 129.49 Million EUR | 137.86% |
| 2020 Q4 | 203.58 Million EUR | 93.12% |
| 2020 Q3 | 105.41 Million EUR | -18.59% |
| 2020 FY | 407.53 Million USD | 60.42% |
| 2020 Q1 | 54.44 Million EUR | -51.39% |
| 2019 Q1 | 60.12 Million EUR | -7.27% |
| 2019 FY | 254.04 Million USD | 0.0% |
| 2019 Q4 | 111.99 Million EUR | 84.8% |
| 2019 Q3 | 60.6 Million EUR | -53.45% |
| 2019 Q2 | 130.19 Million EUR | 116.54% |
| 2018 Q2 | 59.73 Million EUR | -5.29% |
| 2018 Q1 | 63.06 Million EUR | 5.9% |
| 2018 Q4 | 64.83 Million EUR | 19.6% |
| 2018 Q3 | 54.21 Million EUR | -9.24% |
| 2017 Q3 | 52.47 Million EUR | -13.45% |
| 2017 Q1 | 53.66 Million EUR | 5.77% |
| 2017 Q4 | 59.55 Million EUR | 13.49% |
| 2017 Q2 | 60.63 Million EUR | 12.98% |
| 2016 Q4 | 50.73 Million EUR | 2.99% |
| 2016 Q2 | 50.32 Million EUR | 10.17% |
| 2016 Q1 | 45.67 Million EUR | 1.89% |
| 2016 Q3 | 49.26 Million EUR | -2.1% |
| 2015 Q2 | 44.98 Million EUR | 20.07% |
| 2015 Q3 | 44.18 Million EUR | -1.77% |
| 2015 Q4 | 44.83 Million EUR | 1.46% |
| 2015 Q1 | 37.46 Million EUR | -11.26% |
| 2014 Q2 | 44.45 Million EUR | 3.12% |
| 2014 Q3 | 39.75 Million EUR | -10.57% |
| 2014 Q4 | 42.21 Million EUR | 6.19% |
| 2014 Q1 | 43.11 Million EUR | -8.99% |
| 2013 Q2 | 48.45 Million EUR | 13.89% |
| 2013 Q4 | 47.36 Million EUR | 8.13% |
| 2013 Q1 | 42.54 Million EUR | 0.0% |
| 2013 Q3 | 43.8 Million EUR | -9.58% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | 19084.541% |
| Arrayit Corporation | -3.62 Million USD | 6608.953% |
| Atlantic International Corp. | -5.73 Million USD | 4213.173% |
| Biocept, Inc. | -31.98 Million USD | 837.229% |
| Bioqual, Inc. | -19.63 Thousand USD | 1200772.166% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | 30636.87% |
| DermTech, Inc. | -103.73 Million USD | 327.29% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 90.519% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 1231.985% |
| iMD Companies, Inc. | -175.44 Thousand USD | 134493.489% |
| IDenta Corp. | -1499.00 USD | 15729786.458% |
| Interpace Biosciences, Inc. | 2.8 Million USD | -8308.987% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | -609328.793% |
| InVitro International | -25.33 Thousand USD | 930633.96% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | 3410.699% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | 405847.522% |
| Medical Imaging Corp. | -819.48 Thousand USD | 28872.88% |
| NovelStem International Corp. | -3.52 Million USD | 6787.505% |
| Optigenex Inc. | 1.39 Million USD | -16852.981% |
| PharmChem, Inc. | 973.14 Thousand USD | -24129.433% |
| Proteome Sciences plc | -1.62 Million USD | 14645.836% |
| Response Genetics, Inc | -21.37 Million USD | 1202.999% |
| Rennova Health, Inc. | -1.4 Million USD | 16828.082% |
| RushNet, Inc. | -684.7 Thousand USD | 34536.436% |
| ScreenPro Security Inc. | -2.59 Million USD | 9195.257% |
| Stella Diagnostics Inc. | -11.42 Million USD | 2163.438% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | 3143.698% |
| Todos Medical Ltd. | -9.74 Million USD | 2518.835% |